Anuh Pharma Limited (BOM:506260)
82.72
+2.32 (2.89%)
At close: Apr 16, 2026
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 8.06 billion as of April 16, 2026. Its market cap has increased by 0.16% in one year.
Market Cap
8.06B
Enterprise Value
7.93B
Revenue
7.68B
Ranking
n/a
PE Ratio
19.26
Stock Price
82.72
Market Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 8.06B, an increase of 3,571.97%. That is a compound annual growth rate of 21.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 8.29B | 2.78% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 13.90B |
| TTK Healthcare | 12.45B |
| Lincoln Pharmaceuticals | 11.54B |
| Fermenta Biotech | 9.59B |
| Fredun Pharmaceuticals | 8.80B |
| Wanbury | 8.66B |
| Bharat Parenterals | 8.51B |
| Kopran | 7.59B |